Who’s Hired? Ananth Returns To Teva As New API Chief

As Strides Switches COO And Civica Rx Announces Sterile Injectables Site Manager

Teva has announced that R. Ananthanarayanan – known as Ananth – is to rejoin the company as CEO of its active pharmaceutical ingredients business after taking leading roles at Cipla and Strides in recent years. Meanwhile, Strides has disclosed a change of chief operating officer coming next year, while Civica Rx has named a manager for its sterile injectables operations.

Welcome back spelled out in tiles
R. Ananthanarayanan is returning to Teva • Source: Shutterstock

More from Leadership

More from Generics Bulletin